SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1165)6/28/2005 3:55:55 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
ARIA Is continuing yesterday's upmove going through the resistance at 6 with intention of trying to test its May 10 H at 7.40 <g>

Oppenheimer initiated coverage today with a "buy" rating.

The revenues for the 1st Q were 58% better but the loss was higher ($0.23/shr vs. $0.13/shr)

ARIA has a Debt/Equt around 0.16 and probably has enough resources to continue its research on products for the oncology market for a while longer.<g>

bigcharts.marketwatch.com

Bernard



To: Jibacoa who wrote (1165)9/2/2005 4:34:17 PM
From: Jibacoa  Respond to of 3722
 
DRRX was able to trade at its July 21 H of 6.50 at 3.40 and 3.42PM but after the intraday double top it closed at 6.32 <g>

Today it was started as a "buy" by MDB and was able to close up more than 6%. Will have to wait until Tuesday to see if it can go over the 6.50 hurdle.

bigcharts.marketwatch.com

Bernard


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News